Article info
Ovarian cancer
708 Preclinical studies support therapeutic application of the leukaemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer
Citation
708 Preclinical studies support therapeutic application of the leukaemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer
Publication history
- First published October 12, 2021.
Online issue publication
October 12, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.